FOSSE MASTER ISSUER
PLC
(a public company incorporated with limited liability in England
and Wales with registered number 05925693) (the Company)
Publication of Final Terms and Pricing
Supplement
The following final terms (the Final Terms) are available for
viewing:
Issue of £750,000,000 Series
2024-1 Class A1 Floating Rate Notes due October 2072
(Reg S ISIN Code: XS2811884530) under the Residential Mortgage
Backed Note Programme (the Programme) of the Company.
To view the full Final Terms document, please
click on or paste the following URL into the address bar of your
browser:
http://www.rns-pdf.londonstockexchange.com/rns/4081O_1-2024-5-14.pdf
A copy of the above Final Terms has been
submitted to the National Storage Mechanism and will shortly be
available for inspection at: https://data.fca.org.uk/#/nsm/nationalstoragemechanism.
The Final Terms will also shortly be available
for inspection at:
https://www.santander.co.uk/about-santander/investor-relations/fosse-master-trust.
The following pricing supplement (the
Pricing Supplement) is
available for viewing:
Issue of £10,000,000 Series 2024-1
Class Z Variable Funding Note under the Programme of
the Company.
To view the full Pricing Supplement document,
please paste the following URL into the address bar of your
browser:
http://www.rns-pdf.londonstockexchange.com/rns/4081O_2-2024-5-14.pdf
The Pricing Supplement will also be available
for viewing at:
https://www.santander.co.uk/about-santander/investor-relations/fosse-master-trust.
In addition, certain amendments have been made
to the mortgage sale agreement and the master definitions and
construction schedule and will shortly be available for inspection
at
https://www.santander.co.uk/about-santander/investor-relations/fosse-master-trust.
For further information, please
contact:
Medium Term Funding
Santander UK plc
2 Triton Square
Regent's Place
London NW1 3AN
Email:
mtf@santander.co.uk
DISCLAIMER -
INTENDED ADDRESSEES
Please note that the information contained in
the Final Terms, the Pricing Supplement and the base prospectus
published in relation to the Programme on 16 June 2023 as
supplemented on 5 July 2023 (the Prospectus) may be addressed to and/or
targeted at persons who are residents of particular countries only
(as further specified in the Final Terms, the Pricing Supplement
and the Prospectus) and is not intended for use and should not be
relied upon by any person outside these countries and/or to whom
the offer contained in the Final Terms, the Pricing Supplement and
the Prospectus is not addressed. Prior to relying on the
information contained in the Final Terms, the Pricing Supplement
and the Prospectus, you must ascertain from the Final Terms, the
Pricing Supplement and the Prospectus whether or not you are part
of the intended addressees of the information contained
therein.
Your right to access this service is
conditional upon complying with the above requirement.
The securities described herein have not been,
and will not be, registered under the U.S. Securities Act of 1933,
as amended (the Securities Act), or under any relevant securities
laws of any state of the United States of America, and may not be
offered or sold in, the United States of America, or to, or for the
benefit of, U.S. persons (as defined in Regulation S of the
Securities Act) except in transactions that occur outside the
United States to persons other than U.S. persons in accordance with
Regulation S or in other transactions exempt from registration
under the Securities Act and, in each case, in compliance with
applicable securities laws.